Edwards Lifesciences (LTS:0REN) Current Accrued Expense : CHF413 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences Current Accrued Expense?

Edwards Lifesciences's Current Accrued Expense for the quarter that ended in Mar. 2024 was CHF413 Mil.

Edwards Lifesciences's quarterly Current Accrued Expense declined from Sep. 2023 (CHF391 Mil) to Dec. 2023 (CHF388 Mil) but then increased from Dec. 2023 (CHF388 Mil) to Mar. 2024 (CHF413 Mil).

Edwards Lifesciences's annual Current Accrued Expense increased from Dec. 2021 (CHF332 Mil) to Dec. 2022 (CHF367 Mil) and increased from Dec. 2022 (CHF367 Mil) to Dec. 2023 (CHF388 Mil).

Edwards Lifesciences Current Accrued Expense Historical Data

The historical data trend for Edwards Lifesciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Current Accrued Expense Chart

Edwards Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

248.89

276.65

331.65

366.86

387.52

Edwards Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															405.09	389.24	390.70	387.52	413.38

Edwards Lifesciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Edwards Lifesciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (LTS:0REN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

EW:USA EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil EWLS:Austria

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines